Better use of repeat dispensing would improve patient care

Ash_Soni_0411By Ash Soni, Vice Chair of the English Pharmacy Board
The Government announced today that prescription charges in England will rise from £7.85 to £8.05 on 1st April.

A new report, Prescription Charges and Employment, from The Prescription Charges Coalition has found that the cost of prescription charges prevents over a third of people with long term conditions who pay for their prescriptions from taking their medicines as prescribed. Some face medicines poverty, having to choose between paying for their medication and household expenses such as food or heating. Read more Better use of repeat dispensing would improve patient care

Electronic Cigarettes – an aid to quit or a new harmful lifestyle choice?

Alex Mackinnon 160 x 160By Alex MacKinnon, RPS Director for Scotland

As a pharmacist, I must admit to being really concerned about the way the marketing of e-cigarettes is starting to explode around me. The growth in their sale seems to be rising exponentially with associated marketing spend. New manufacturers are appearing as they recognise a commercial opportunity.

Read more Electronic Cigarettes – an aid to quit or a new harmful lifestyle choice?

The RPS Faculty – What’s it all about?

SPB Sandra Melville_tifBy Sandra Melville, Fellow of the Faculty, FFRPS, a Fellow of the Society, FRPharmS, and a Member of the Scottish Pharmacy Board.

2013 saw the launch of the RPS Faculty amidst a fervent fanfare of rejoicing, frenetically followed by a rush of “First Wavers” who put their summers on hold (not such a sacrifice, some may argue, in Scotland, where it fell on a Tuesday!) in order to be amongst the first to attain Faculty membership. But what was all the fuss about, who is the Faculty for and why should pharmacists bother with what will inevitably be yet another extra-curricular activity? Good questions. Read more The RPS Faculty – What’s it all about?

Viagra: will branded or generic versions make a difference?

OLYMPUS DIGITAL CAMERABy Colin Cable, Pharmaceutical Science Information Adviser

Viagra loses its patent in the UK today. This means that Pfizer, the company that first made Viagra, will no longer have exclusive rights to its production. Instead, other companies will be able to manufacture and sell generic versions of this medicine. Read more Viagra: will branded or generic versions make a difference?